Potent efficiency of the novel nitazoxanide-loaded nanostructured lipid carriers against experimental cyclosporiasis.

Cyclosporiasis is a ubiquitous infection caused by an obligate intracellular protozoan parasite known as Cyclospora cayetanensis (C. cayetanensis). The disease is characterized by severe diarrhea which may be regrettably fatal in immunosuppressed patients. The commercially available treatment option...

Full description

Bibliographic Details
Main Authors: Nancy Abd-Elkader Hagras, Shaimaa Makled, Eman Sheta, Mohamed Ali El-Hawary, Nermine Mogahed Fawzy Hussein Mogahed
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-12-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0011845
_version_ 1797366500574625792
author Nancy Abd-Elkader Hagras
Shaimaa Makled
Eman Sheta
Mohamed Ali El-Hawary
Nermine Mogahed Fawzy Hussein Mogahed
author_facet Nancy Abd-Elkader Hagras
Shaimaa Makled
Eman Sheta
Mohamed Ali El-Hawary
Nermine Mogahed Fawzy Hussein Mogahed
author_sort Nancy Abd-Elkader Hagras
collection DOAJ
description Cyclosporiasis is a ubiquitous infection caused by an obligate intracellular protozoan parasite known as Cyclospora cayetanensis (C. cayetanensis). The disease is characterized by severe diarrhea which may be regrettably fatal in immunosuppressed patients. The commercially available treatment options have either severe side effects or low efficiency. In the present study, the novel formula of nitazoxanide (NTZ)-loaded nanostructured lipid carriers (NLCs) was assessed for the first time for C. cayetanensis treatment in both immunocompetent and immunosuppressed mice in comparison to commercially available drugs (trimethoprim-sulfamethoxazole (TMP-SMX) and NTZ). Swiss Albino mice were orally infected by 104 sporulated oocysts. The experimental groups were treated with the gold standard TMP-SMX, NTZ, blank NLCs and NTZ-loaded NLCs. The results demonstrated that NTZ-loaded NLCs represented the highest significant parasite percent reduction of (>98% reduction) in both immunocompetent and immunosuppressed mice designating successful tissue penetration and avoiding recurrence of infection at the end of the study. Oocysts treated with NTZ-loaded NLCs demonstrated the most mutilated rapturing morphology via scanning electron microscope examination as well as representing the most profound improvement of the histopathological picture. In conclusion, NTZ-loaded NLCs exhibited the uppermost efficacy in the treatment of cyclosporiasis. The safe nature and the anti-parasitic effect of the novel formulation encourage its use as a powerful treatment for human cyclosporiasis.
first_indexed 2024-03-08T17:05:03Z
format Article
id doaj.art-85e49df9e023421aa4146069472c948d
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-03-08T17:05:03Z
publishDate 2023-12-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-85e49df9e023421aa4146069472c948d2024-01-04T05:32:32ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352023-12-011712e001184510.1371/journal.pntd.0011845Potent efficiency of the novel nitazoxanide-loaded nanostructured lipid carriers against experimental cyclosporiasis.Nancy Abd-Elkader HagrasShaimaa MakledEman ShetaMohamed Ali El-HawaryNermine Mogahed Fawzy Hussein MogahedCyclosporiasis is a ubiquitous infection caused by an obligate intracellular protozoan parasite known as Cyclospora cayetanensis (C. cayetanensis). The disease is characterized by severe diarrhea which may be regrettably fatal in immunosuppressed patients. The commercially available treatment options have either severe side effects or low efficiency. In the present study, the novel formula of nitazoxanide (NTZ)-loaded nanostructured lipid carriers (NLCs) was assessed for the first time for C. cayetanensis treatment in both immunocompetent and immunosuppressed mice in comparison to commercially available drugs (trimethoprim-sulfamethoxazole (TMP-SMX) and NTZ). Swiss Albino mice were orally infected by 104 sporulated oocysts. The experimental groups were treated with the gold standard TMP-SMX, NTZ, blank NLCs and NTZ-loaded NLCs. The results demonstrated that NTZ-loaded NLCs represented the highest significant parasite percent reduction of (>98% reduction) in both immunocompetent and immunosuppressed mice designating successful tissue penetration and avoiding recurrence of infection at the end of the study. Oocysts treated with NTZ-loaded NLCs demonstrated the most mutilated rapturing morphology via scanning electron microscope examination as well as representing the most profound improvement of the histopathological picture. In conclusion, NTZ-loaded NLCs exhibited the uppermost efficacy in the treatment of cyclosporiasis. The safe nature and the anti-parasitic effect of the novel formulation encourage its use as a powerful treatment for human cyclosporiasis.https://doi.org/10.1371/journal.pntd.0011845
spellingShingle Nancy Abd-Elkader Hagras
Shaimaa Makled
Eman Sheta
Mohamed Ali El-Hawary
Nermine Mogahed Fawzy Hussein Mogahed
Potent efficiency of the novel nitazoxanide-loaded nanostructured lipid carriers against experimental cyclosporiasis.
PLoS Neglected Tropical Diseases
title Potent efficiency of the novel nitazoxanide-loaded nanostructured lipid carriers against experimental cyclosporiasis.
title_full Potent efficiency of the novel nitazoxanide-loaded nanostructured lipid carriers against experimental cyclosporiasis.
title_fullStr Potent efficiency of the novel nitazoxanide-loaded nanostructured lipid carriers against experimental cyclosporiasis.
title_full_unstemmed Potent efficiency of the novel nitazoxanide-loaded nanostructured lipid carriers against experimental cyclosporiasis.
title_short Potent efficiency of the novel nitazoxanide-loaded nanostructured lipid carriers against experimental cyclosporiasis.
title_sort potent efficiency of the novel nitazoxanide loaded nanostructured lipid carriers against experimental cyclosporiasis
url https://doi.org/10.1371/journal.pntd.0011845
work_keys_str_mv AT nancyabdelkaderhagras potentefficiencyofthenovelnitazoxanideloadednanostructuredlipidcarriersagainstexperimentalcyclosporiasis
AT shaimaamakled potentefficiencyofthenovelnitazoxanideloadednanostructuredlipidcarriersagainstexperimentalcyclosporiasis
AT emansheta potentefficiencyofthenovelnitazoxanideloadednanostructuredlipidcarriersagainstexperimentalcyclosporiasis
AT mohamedalielhawary potentefficiencyofthenovelnitazoxanideloadednanostructuredlipidcarriersagainstexperimentalcyclosporiasis
AT nerminemogahedfawzyhusseinmogahed potentefficiencyofthenovelnitazoxanideloadednanostructuredlipidcarriersagainstexperimentalcyclosporiasis